Patent Cliffs 2025 – 2030: The $300 Billion Reckoning Every pharmaceutical executive knows the phrase. Every investor fears it. Every generic manufacturer counts down to it. The patent cliff represents the precipitous drop in revenue that follows a drug’s loss of exclusivity (LOE) which is one of the most powerful, predictable, and paradoxically disruptive forces […]

A Deep Dive into IP Monopolies The debate over whether patents constitute monopolies is as old as the patent system itself. The term “monopoly” historically refers to the exclusive control of a commodity or service in a particular market, enabling the manipulation of prices. However, this notion must often be more accurate when applied to […]